This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2011-2012.
Company Filing History:
Years Active: 2011-2012
Title: Alexander Glomme: Innovator in Pharmaceutical Chemistry
Introduction
Alexander Glomme is a notable inventor based in Birsfelden, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on specific compounds. With a total of 2 patents, Glomme has established himself as a key figure in the development of new pharmaceutical formulations.
Latest Patents
Glomme's latest patents focus on the solid forms of 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine. The first patent relates to mono-sulfate and hemi-sulfate salts of this compound, detailing their crystalline and amorphous forms and their applications in pharmaceutical formulations. The second patent also addresses solid forms of the same compound, specifically the mono-sulfate salt, crystalline forms A and B, and an amorphous form of the mono-sulfate salt, along with hemi-sulfate salts.
Career Highlights
Throughout his career, Glomme has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in drug development.
Collaborations
Some of Glomme's notable coworkers include Doreen Miller and Jason Yang. Their collaborative efforts have further enhanced the innovative work being done in the field of pharmaceutical chemistry.
Conclusion
Alexander Glomme's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of new and effective pharmaceutical formulations.